TP53 and cancer: Inhibition of HIPK2 attenuates the adriamycin-induced apoptosis by decreasing pSer46-p53 levels, whilst HIPK2 overexpression induces apoptosis in chemoresistant cancer cells, along with induction of p53 Ser46-target gene AIP1 [84].